M Mydlík

487 total citations
62 papers, 347 citations indexed

About

M Mydlík is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Emergency Medicine. According to data from OpenAlex, M Mydlík has authored 62 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Emergency Medicine. Recurrent topics in M Mydlík's work include Poisoning and overdose treatments (11 papers), Dialysis and Renal Disease Management (9 papers) and Vitamin C and Antioxidants Research (7 papers). M Mydlík is often cited by papers focused on Poisoning and overdose treatments (11 papers), Dialysis and Renal Disease Management (9 papers) and Vitamin C and Antioxidants Research (7 papers). M Mydlík collaborates with scholars based in Slovakia, Czechia and Pakistan. M Mydlík's co-authors include Olivér Rácz, Tamás Szabó, A Válek, Tomáš Zima, Ján Buček, A Kohút, J Gonsorčík, A Böör, K Horký and Z Hejl and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and American Journal of Kidney Diseases.

In The Last Decade

M Mydlík

55 papers receiving 329 citations

Peers

M Mydlík
D. Verbeelen Belgium
Henk J. Huijgen Netherlands
A.I. Macdougall United Kingdom
D Boda Hungary
William B. Blythe United States
P Vogeleere Belgium
M Mydlík
Citations per year, relative to M Mydlík M Mydlík (= 1×) peers S Biasioli

Countries citing papers authored by M Mydlík

Since Specialization
Citations

This map shows the geographic impact of M Mydlík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Mydlík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Mydlík more than expected).

Fields of papers citing papers by M Mydlík

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Mydlík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Mydlík. The network helps show where M Mydlík may publish in the future.

Co-authorship network of co-authors of M Mydlík

This figure shows the co-authorship network connecting the top 25 collaborators of M Mydlík. A scholar is included among the top collaborators of M Mydlík based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Mydlík. M Mydlík is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mydlík, M, et al.. (2013). Renal replacement therapy in acute poisonings--one center experience.. PubMed. 70(6). 381–5. 8 indexed citations
2.
Mydlík, M. (2011). Jan Brod and his contributions to hypertension and nephrology. Journal of Nephrology. 24(Suppl. 17). 73–77.
3.
Mydlík, M, et al.. (2010). Vitamin B6 and Oxalic Acid in Clinical Nephrology. Journal of Renal Nutrition. 20(5). S95–S102. 16 indexed citations
4.
Mydlík, M, et al.. (2008). Vitamins and quality of life in hemodialysis patients. Journal of Nephrology. 21(S13). S129–S133. 3 indexed citations
5.
Mydlík, M, et al.. (2007). Robert Klopstock and Franz Kafka--the friends from Tatranské Matliare (the High Tatras).. PubMed. 108(2). 191–5. 1 indexed citations
6.
Mydlík, M, et al.. (2007). Oxalic Acid as a Uremic Toxin. Journal of Renal Nutrition. 18(1). 33–39. 12 indexed citations
7.
Mydlík, M, et al.. (2005). The disease of Franz Kafka.. PubMed. 106(3). 307–13. 2 indexed citations
8.
Mydlík, M, et al.. (2004). Vitamin E-coated dialyzer and antioxidant defense parameters: Three-month study. Seminars in Nephrology. 24(5). 525–531. 14 indexed citations
9.
Mydlík, M, et al.. (2003). Oral use of iron with vitamin C in hemodialyzed patients. Journal of Renal Nutrition. 13(1). 47–51. 7 indexed citations
10.
Mydlík, M, et al.. (2001). Renal replacement therapy and secondary hyperoxalemia in chronic renal failure. Kidney International. 59. S304–S307. 13 indexed citations
11.
Mydlík, M, et al.. (2001). Renal replacement therapy and secondary hyperoxalemia in chronic renal failure. Kidney International. 59(s78). 304–307. 6 indexed citations
13.
Mydlík, M, et al.. (1997). Metabolism of vitamin B6 and its requirement in chronic renal failure.. PubMed. 62. S56–9. 31 indexed citations
14.
Mydlík, M, et al.. (1996). Saccharomyces Cerevisiae Peritonitis Complicating Capd. Peritoneal Dialysis International. 16(2). 188–189. 6 indexed citations
15.
Mydlík, M, et al.. (1995). [Hemoperfusion with Amberlite XAD-4 in acute theophylline poisoning].. PubMed. 134(5). 145–6. 1 indexed citations
16.
Mydlík, M, et al.. (1993). [Hemoperfusion in mushroom poisoning. Clinical analysis of 58 patients].. PubMed. 132(15). 464–7. 6 indexed citations
17.
Mydlík, M, et al.. (1992). Vitamin B6 requirements in chronic renal failure. International Urology and Nephrology. 24(4). 453–457. 1 indexed citations
18.
Mydlík, M, et al.. (1991). Serum vitamin A, retinyl esters and vitamin E in nephrotic syndrome. International Urology and Nephrology. 23(4). 399–405. 8 indexed citations
19.
Mydlík, M, et al.. (1976). Serum lipids and lipoproteins in acute renal failure.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 12. 389–96. 1 indexed citations
20.
Mydlík, M, et al.. (1976). [L-ascorbic acid and long-term dialysis program].. PubMed. 115(4). 115–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026